UK Campaigners Call for More Medical Cannabis Access, Two Years on From Decision to Legalize
In an open letter to the country’s home secretary, Hannah Deacon highlights how medical cannabis remains largely unavailable to patients via the National Health Service.
Colorado Adds to List of Acceptable Cannabis Pesticides
Since the start of May this year, the state department has added nine pesticide products to the list, which now exceeds 400 compounds.
Sapphire Medical Clinics Launches Registry to Expand Medical Cannabis Evidence Base in the UK
The registry aims to collect and analyze clinical information from patients taking medical cannabis treatments in the UK for all recognized eligible conditions.
Medical Cannabis Shouldn’t Always Be Considered a Last Resort, Says Review
Written by some of the country’s top drug science and policy researchers, the review puts forward a number of ‘next steps’ for the country to consider pursuing in order to better support prospective medical cannabis patients in the UK.
10 Out of 37 CBD Products Are Inaccurately Labeled, Says Nevada Lab
A partner in the testing review says the findings provide further proof that consumers should only buy from reputable CBD brands.
Researchers Believe Cannabinoids Could Treat HIV-associated Disorders
Researchers at George Mason University have received $450,000 in funding from the National Institutes of Health to pursue new research into whether cannabinoids can help treat HIV-associated disorders.
Cannabis Use During Late Pregnancy Linked to Lower Birth Weights, Study Finds
Compared with babies of mothers who had never used cannabis, infants of those who still consumed the drug after 15 weeks had lower mean values for birthweight, birth length, and head circumference.
Cannabis Concentrates Don’t Get Consumers Any Higher, Study Finds
The researchers aren’t sure exactly how those who used the concentrates could have such high THC levels without incurring greater intoxication, but they suspect a tolerance may have been built up.
French Medical Cannabis Pilot Delayed Until January 2021
Initially scheduled to begin in September, the need to tackle the coronavirus pandemic means that the medical cannabis program will be postponed until January 2021 at the latest.
